5610325 VARIABILITY OF OXYGENSCAN PARAMETERS ACCORDING TO THE TYPE OF THERAPY IN CHILDREN WITH SICKLE CELL DISEASE: PRELIMINARY DATA FROM A FEASIBILITY STUDY

5610325 VARIABILITY OF OXYGENSCAN PARAMETERS ACCORDING TO THE TYPE OF THERAPY IN CHILDREN WITH SICKLE CELL DISEASE: PRELIMINARY DATA FROM A FEASIBILITY STUDY

Bibliographic Details
Main Authors:	G. Reggiani, M. Martella, V. Munaretto, I. Baido, M.P. Boaro, A. Biffi, L. Sainati, R. Colombatti
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000928228.78961.a8

Similar Items

Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease
by: Camille Boisson, et al.
Published: (2021-04-01)

5612627 MORTALITY, CHRONIC MORBIDITY AND INTENSITY OF TREATMENTS IN A NATURAL HISTORY COHORT OF SICKLE CELL DISEASE
by: G. Reggiani, et al.
Published: (2023-04-01)

P118: THE ROLE OF HEMOGLOBIN AND HEMOLYSIS ON TRANSCRANIAL DOPPLER VELOCITIES IN CHILDREN WITH SICKLE CELL DISEASE: DATA FROM A NATURAL HISTORY COHORT
by: G Reggiani, et al.
Published: (2022-01-01)

P1682: HEALTH RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE: ARE WE SURE TO GET IT RIGHT? PATIENTS AND PARENTS MIGHT HAVE DIFFERENT OPINIONS.
by: Desiré Fantasia, et al.
Published: (2023-08-01)

MANAGEMENT OF CHILDREN WITH SICKLE CELL DISEASE IN EUROPE: CURRENT SITUATION AND FUTURE PERSPECTIVES
by: Raffaella Colombatti, et al.
Published: (2016-07-01)

5613386 CELEBRATING THE SICKLE CELL DISEASE WORLD DAY ON JUNE 19TH AFTER TWO YEARS OF PANDEMIC: MY LIFE WITH SCD, PATIENTS’ PERSPECTIVE
by: J.E.M. Maran, et al.
Published: (2023-04-01)

Hematological characteristics and hepatobiliary complications of hereditary spherocytosis in a tertiary care pediatric center: optimizing diagnosis and care through local and international networks
by: Maria Paola Boaro, et al.
Published: (2023-10-01)

5613274 “A PICTURE IS OFTEN WORTH MORE THAN MANY WORDS: STREET ART AS EMPOWERMENT FOR SICKLE CELL DISEASE PATIENTS” JACKELINE ELIZABETH MARAN1, MARINA PERDIBON1, ILARIA BAIDO1, MICHEL NKONGNE GYSLENE2,FABRIZIO CANONICI2, VANIA MUNARETTO3-4, GIULIA REGGIANI3-4, LAURA SAINATI4, ALESSANDRA BIFFI3-4, RAFFAELLA C
by: J.E.M. Maran, et al.
Published: (2023-04-01)

Evaluation of Technical Issues in a Pilot Multicenter Newborn Screening Program for Sickle Cell Disease
by: Maddalena Martella, et al.
Published: (2018-12-01)

Primary stroke prevention for sickle cell disease in north-east Italy: the role of ethnic issues in establishing a Transcranial Doppler screening program
by: Pierobon Marta, et al.
Published: (2009-06-01)

P134: THE AREAL PROJECT: A VIRTUAL REALITY APPLICATION TO SUPPORT THE THERAPEUTIC EXPERIENCE AND THERAPY EDUCATION OF ADULT PATIENTS WITH THALASSEMIA AND SICKLE CELL DISEASE
by: V Megale, et al.
Published: (2022-01-01)

P1500: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE
by: S. van der Veen, et al.
Published: (2022-06-01)

Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study.
by: Raffaella Colombatti, et al.
Published: (2016-01-01)

Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic review.
by: Mazzucco, S, et al.
Published: (2017)

5613081 GAPS IN DATA ON GLOBAL PREVALENCE AND BIRTH PREVALENCE OF SICKLE CELL DISEASE AND SICKLE CELL TRAIT: CALL FOR ACTION TO SCALE UP AND HARMONIZE DATA COLLECTION
by: R. Colombatti, et al.
Published: (2023-04-01)

PB2215: GLOBAL EPIDEMIOLOGY OF SICKLE CELL DISEASE: A SYSTEMATIC LITERATURE REVIEW
by: R. Colombatti, et al.
Published: (2022-06-01)

Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation
by: Raffaella Colombatti, et al.
Published: (2011-09-01)

P-023: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE
by: VAN DER VEEN S., et al.
Published: (2022-08-01)

P-032: INTEGRATIVE DIAGNOSIS OF SICKLE CELL DISEASE PATIENTS FOR PERSONALIZED MEDICINE
by: IDRIZOVIC A., et al.
Published: (2022-08-01)

Systematic Literature Review Shows Gaps in Data on Global Prevalence and Birth Prevalence of Sickle Cell Disease and Sickle Cell Trait: Call for Action to Scale Up and Harmonize Data Collection
by: Raffaella Colombatti, et al.
Published: (2023-08-01)

P1478: INTEGRATIVE DIAGNOSIS OF SICKLE CELL DISEASE PATIENTS FOR PERSONALIZED MEDICINE
by: A. Idrizovic, et al.
Published: (2022-06-01)

PI-11: EXTREME VARIABILITY OF THE PROGNOSTIC VALUE OF BIOLOGICAL PARAMETERS ACCORDING TO STATISTICAL METHODOLOGY IN PEDIATRIC SICKLE CELL DISEASE COHORT STUDIES
by: SOMMET J., et al.
Published: (2022-08-01)

Environmental Factors in Northern Italy and Sickle Cell Disease Acute Complications: A Multicentric Study
by: Maria Elena Guerzoni, et al.
Published: (2022-09-01)

Editorial for Special Issue “Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies”
by: Raffaella Colombatti, et al.
Published: (2019-09-01)

Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority
by: Raffaella Colombatti, et al.
Published: (2021-07-01)

Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.
by: Raffaella Colombatti, et al.
Published: (2013-01-01)

Sickled red blood cells in urine: A preliminary indicator for the detection of sickle cell trait
by: Neha Garg, et al.
Published: (2019-01-01)

Preliminary testing of the internal gear pump with modifications of the sickle insert
by: Piotr Antoniak, et al.
Published: (2019-07-01)

Current challenges in the management of patients with sickle cell disease – A report of the Italian experience
by: Giovanna Russo, et al.
Published: (2019-05-01)

O-02: RADIOMICS AND ARTIFICIAL INTELLIGENCE FOR IDENTIFICATION AND MONITORING OF SILENT CEREBRAL INFARCTS IN SICKLE CELL DISEASE: FIRST ANALYSIS FROM THE GENOMED4ALL EUROPEAN PROJECT
by: BIONDI R., et al.
Published: (2022-08-01)

Management of the Sickle Cell Trait: An Opinion by Expert Panel Members
by: Valeria Maria Pinto, et al.
Published: (2023-05-01)

Moderate dose of hydroxyurea in children with sickle cell disease and stroke. Preliminary results
by: Sergio Machín-García, et al.

S265: RADIOMICS AND ARTIFICIAL INTELLIGENCE FOR IDENTIFICATION AND MONITORING OF SILENT CEREBRAL INFARCTS IN SICKLE CELL DISEASE: FIRST ANALYSIS FROM THE GENOMED4ALL EUROPEAN PROJECT
by: M. P. Boaro, et al.
Published: (2022-06-01)

5613512 ASSESSMENT OF CHRONIC PAIN IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE IN ITALY: PRELIMINARY RESULTS OF A PROSPECTIVE STUDY C.PIATTELLINI1, V.MUNARETTO2, G.REGGIANI2, I.BAIDO2, E.MARAN2, A.BIFFI2, F.BENINI1, A.ZANIN1 AND R.COLOMBATTI2
by: C.P. Piattellini, et al.
Published: (2023-04-01)

Preliminary evidence that hydroxyurea is associated with attenuated peripheral sensitization in adults with sickle cell disease
by: Janelle E. Letzen, et al.
Published: (2019-04-01)

Newborn Screening for Sickle Cell Disease in Europe
by: Yvonne Daniel, et al.
Published: (2019-02-01)

The effect of intermittent fasting on the clinical and hematological parameters of patients with sickle cell disease: A preliminary study
by: Khalid Ahmed, et al.
Published: (2023-02-01)

Feasibility and Quality Validation of a Mobile Application for Enhancing Adherence to Opioids in Sickle Cell Disease
by: Daniel M. Sop, et al.
Published: (2022-08-01)

P129: NARRATING SICKLE CELL DISEASE: THE EXPERIENCES OF PATIENTS AND CARGIVERS
by: L De Franceschi, et al.
Published: (2022-01-01)

Feasibility of Electronic Medication Monitoring Among Adolescents and Emerging Adults with Sickle Cell Disease
by: Hildenbrand AK, et al.
Published: (2023-12-01)